Contact
Please use this form to send email to PR contact of this press release:
Nexien BioPharma, Inc. has been Issued a U.S. Patent for the Methods and Compositions for Treating Myotonic Dystrophies
TO:
Richard Greenberg
Nexien BioPharma, Inc
+1 303-807-2551